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Abstract
Background: Mammalian meat is the most common trigger of the allergic reactions in 
patients with α- Gal syndrome (AGS). Milk and dairy, although less often, also cause 
a significant number of allergic manifestations. The aim of this study was to identify 
α- Gal- containing bovine milk proteins with allergenic properties among AGS patients.
Methods: Thirty- eight AGS patients with IgE to milk were included in the study. Milk 
proteins were analyzed for the presence of α- Gal and for binding by patients’ IgE using 
immunoblot, ImmunoCAP, and inhibition ELISA. Allergenicity of milk and milk proteins 
was assessed by basophil activation test.
Results: More than half of the AGS patients reported allergic reactions to milk or 
dairy products. Bovine γ- globulin (BGG), lactoferrin (LF), and lactoperoxidase (LPO) 
were identified as α- Gal carrying proteins which were recognized by AGS patients’ 
IgE. Whey mirrored the anti- α- Gal and IgE reactivity of BGG, LF, and LPO. Eighty- nine 
percent of the patients displayed IgE to BGG, 91% to LF, and 57% to LPO. Inhibition 
of α- Gal- specific IgE binding was achieved by BGG, LF, LPO, and whey. These proteins 
also activated AGS patients’ basophils. Interestingly, at lower concentrations, LF was 
the most potent inhibitor of IgE binding, and the most potent activator of basophils.
Conclusion: BGG, LF, and LPO were all found to be relevant milk α- Gal- containing 
glycoproteins that bound AGS patients’ IgE antibodies and activated their basophils. 
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1  |  INTRODUC TION
More than a decade ago, the carbohydrate galactose- α- 1,3- galactose 
(α- Gal) was identified as an IgE epitope that mediates allergic reac-
tions in a novel form of food allergy known as the α- Gal syndrome 
(AGS).1,2 The α- Gal epitope is expressed on glycoproteins and glyco-
lipids of non- primate mammals but is also present in some pharma-
ceuticals. AGS is characterized by late- onset symptoms, usually two 
to six hours after mammalian meat consumption,3 which is in con-
trast to common food allergies where the reactions are immediate. 
The symptoms range from abdominal pain, urticaria to anaphylaxis, 
and are often severe. Notably, nearly 50% of the patients experi-
ence anaphylaxis.4 The syndrome typically develops in middle- aged 
patients who have previously tolerated mammalian meat.5,6 The in-
duction of the disease has been shown to be associated with tick 
bites.7 The first AGS cases were reported in the United States in 
2009, shortly followed by reports from Sweden and Australia, and 
today the syndrome is diagnosed worldwide and its prevalence con-
tinues to rise.1,8,9
Mammalian meat (beef, pork, and lamb) and especially innards, 
which are abundant in α- Gal content, are the most common food 
sources that induce allergic reactions in AGS patients. Other foods 
that contain α- Gal in lesser amounts are bovine milk and mammalian 
gelatin.10– 12 Many AGS patients experience allergic reactions upon 
milk and dairy consumption.13 IgE reactivity to bovine milk has been 
observed in more than 90% in our cohort of 128 AGS patients and in 
nearly 70% in a US cohort of 261 patients.4,6 Furthermore, a study 
on 100 randomly selected AGS patients from a US cohort showed 
that 33% of the allergic manifestations were triggered by dairy.14 In 
addition, analysis of a large US cohort of 2500 AGS patients revealed 
that 10– 20% of patients reacted to milk.15 The most commonly re-
ported symptoms to bovine milk were abdominal pain and urticaria 
with delayed onset.16,17
To date, no milk glycoproteins or glycolipids that carry α- Gal have 
been identified. This is in contrast to meat, where proteins that carry 
α- Gal have been thoroughly investigated.18– 20 Kollmann et al have 
shown that bovine γ- globulin (BGG) is the most prominent carrier of 
α- Gal and IgE reactive glycoprotein in beef.19 Interestingly, BGG is 
present in milk as well.
The aim of this study was to elucidate the importance of bovine 
milk as an α- Gal- containing food source. The focus was to charac-
terize AGS patients’ IgE responses to milk proteins, to identify α- Gal 
carrying milk glycoproteins, and assess their allergenicity among AGS 
patients.
of Republic of Serbia, Grant/Award 
Number: 451- 03- 68/2020- 14/200168 and 
451- 03- 68/2020- 14/200288; European 
Cooperation in Science and Technology, 
Grant/Award Number: FA1402
These proteins are probably involved in the allergic reactions to milk in AGS patients. 
LPO was for the first time shown to be an allergen.
K E Y W O R D S
bovine γ- globulin, lactoferrin, lactoperoxidase, milk, α- Gal syndrome
G R A P H I C A L  A B S T R A C T
More than half of the AGS patients reported allergic reactions to milk or dairy products. Bovine γ- globulin, lactoferrin, and lactoperoxidase 
were found to be relevant milk α- Gal- containing glycoproteins that bound AGS patients’ IgE antibodies and activated their basophils. These 
proteins are probably involved in the allergic reactions to milk and dairy products in AGS patients. Abbreviations: α- Gal, galactose- α- 1,3- 
galactose; AGS, α- Gal syndrome; kUA/L, kilo units of allergen- specific IgE per liter.
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2  |  MATERIAL S AND METHODS
2.1  |  Patient cohort and ethics statement
Thirty- eight patients with IgE to milk were selected from our cohort 
of patients with diagnosed AGS (Table 1). The selection was rand-
omized among almost all available patients (91.4% have IgE to milk4). 
A total of 34/38 answered a questionnaire and were interviewed by 
the same allergologist with many years of experience in food allergy, 
regarding milk and dairy consumption and tolerance. Patients’ sera 
were collected and either used individually or as a pool. In addition, 
three healthy non- atopic and two atopic donors participated in the 
study as controls. Allergen- specific IgE levels against α- Gal (bovine 
thyroglobulin), milk, α- lactalbumin, β- lactoglobulin, and caseins were 
determined by ImmunoCAP (Phadia AB/Thermo Fisher Scientific). IgE 
antibodies against BGG, LF, LPO, and whey were measured by cou-
pling biotinylated BGG, LF, LPO, and whey proteins to Streptavidin 
ImmunoCAP (Phadia AB/Thermo Fisher Scientific) according to the 
manufacturer's instructions. The cutoff for allergen- specific IgE was 
≥0.1 kUA/L. The study was approved by the Swedish ethical review 
authority (Ethical permit No 2011/1604- 31/2, 2018/2483- 32) and 
performed in accordance with the declaration of Helsinki. All AGS 
patients and controls gave their written informed consent.
2.2  |  Materials and reagents
Unprocessed milk was obtained from a local farm in Belgrade. 
Commercially available pasteurized 3% and 1.5% fat milk were pur-
chased from a Swedish dairy company (Arla Foods). Commercial pas-
teurized milk was homogenized and pasteurized at low temperature 
(72– 75°C for less than 15 s). Whey was prepared from unprocessed milk 
as follows. Unprocessed milk was centrifuged at 4000 rpm for 20 min at 
+4°C, and the upper lipid layer was removed. Caseins were precipitated 
by lowering the pH to 4.6 by adding 0.1 M HCl and removed by centrifu-
gation at 4000 rpm for 10 min. The resulting whey was further defatted 
by tetrachlorethylene extraction. Defatted whey was dialyzed against 
ammonium bicarbonate buffer, lyophilized, and subsequently dissolved 
in PBS. Protein concentration was determined by the BCA method. The 
protein concentration of pasteurized milks was 34 mg/ml as per manu-
facturer's information. Throughout the study, ultra- pure water (18 mΩ) 
prepared with a Smart2Pure 3 Barnstead aqua purification system 
(Thermo Fisher Scientific Inc.) was used. Unless otherwise stated, all 
the other chemicals were purchased from Sigma- Aldrich.
2.3  |  SDS- PAGE and immunoblot
Purified milk proteins, α- casein, β- casein, κ- casein, α- lactalbumin, β- 
lactoglobulin, BGG, lactoferrin (LF), lactoperoxidase (LPO), bovine 
serum albumin (BSA) (1.5 µg each, Sigma- Aldrich), and whey (15 µg) 
were separated under reducing conditions on SDS- PAGE electropho-
resis at TGX gradient precast gels (any kDa, Bio- Rad Laboratories) 
using a Mini Protean Cell II system (Bio- Rad Laboratories). Proteins 
were transferred to PVDF membranes (0.2 µm pore size) using a Bio- 
Rad Turbo system. Membranes were blocked with 2% human serum 
albumin (HSA) in phosphate- buffered saline containing 0.05% Tween 
(t- PBS) for 2 h at room temperature (RT).
The IgE binding to milk proteins and whey was probed by incubat-
ing the membrane with a serum pool of AGS patients (#1– 13, Table 1; 
37 kUA/L to α- Gal) diluted 1:5 overnight with agitation. For inhibi-
tion of IgE binding, the serum pool was preincubated with 150 µg/
ml of bovine thyroglobulin for 2 h prior to addition to the membrane. 
Bound IgE was detected with mouse anti- human IgE labeled with 
horseradish peroxidase (1:2000, Abcam) for 1 h at RT. Visualization 
was performed with luminol and H2O2 substrates (GE Healthcare) 
on a ChemiDoc instrument (Bio- Rad Laboratories). Serum from a 
healthy non- atopic individual (diluted 1:5) was used as control.
To detect α- Gal carrying milk proteins, the membrane was incu-
bated with 1:7500 dilution of chicken anti- α- Gal single- chain anti-
body variable- region fragment (scFv) (National University of Ireland, 
Galway)21 labeled with hemagglutinin tag for 2 h at RT. Subsequently, 
the membrane was incubated with 0.25 µg/ml mouse monoclonal 
anti- hemagglutinin antibody (Cat. No. H3663) for 1 h, followed by 
goat anti- mouse IgG labeled with alkaline phosphatase (AP) (1:1000, 
Jackson ImmunoResearch Laboratories). AP Conjugate Substrate Kit 
(Bio- Rad Laboratories) was used for visualization.
2.4  |  Inhibition ELISA
The ability of milk and milk proteins (BGG, LF, LPO, and whey) to in-
hibit IgE binding to α- Gal- HSA was investigated by inhibition ELISA. 
Microtiter plates were coated with 2.5 µg/ml α- Gal- HSA in coat-
ing buffer overnight at +4°C. Individual AGS patients’ sera (dilution 
1:20) or a serum pool (dilution 1:20) were preincubated with two- 
fold serial dilutions of α- Gal- HSA (500– 3.9 µg/ml), BGG, LF, LPO, 
whey (1000– 7.8 µg/ml), unprocessed milk, and pasteurized 3% and 
1.5% fat milk (10 steps of two- fold dilution) for 2h at RT. Thereafter, 
the remaining IgE binding to plate- bound α- Gal- HSA was detected 
with rabbit anti- human IgE (1:2000; Miab) for 1 h at RT, followed by 
AP- labeled goat anti- rabbit IgG (1:1000, Jackson ImmunoResearch 
Laboratories) for 1 h at RT. Chromogenic 4- nitrophenyl phosphate 
substrate was used for visualization, and the reaction was stopped 
with 3 N NaOH. The optical density (O.D.) was read at 405 nm. 
Inhibition of IgE binding was calculated according to the following 
equation: % of inhibition = 100 − [O.D. (inhibited) × 100/O.D. (non- 
inhibited)]. Inhibition ELISA experiments were performed in dupli-
cates and results are represented as average values ±SD.
2.5  |  Basophil activation test
Heparinized blood samples were collected from 25 AGS patients 
(#7– 13, 22– 39 in Table 1), two atopic, and two non- atopic indi-
viduals. Blood aliquots (90 µl) were incubated with stimulants in a 
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1:1 ratio for 25 min at 37°C. BGG, LF, LPO, whey (0.1– 200 µg/ml), 
and pasteurized 3% fat milk (100– 1000 times diluted) were used 
as stimulants. Anti- FcεRI (Bühlmann Laboratories AG) was used as 
positive control and PBS as unstimulated control. Cells were stained 
with FITC- conjugated anti- CD63 and PE- conjugated anti- CD203c 
monoclonal antibodies (clones CLBGran/12 and 97A6, respectively, 
Immunotech) at +4°C. Basophils were analyzed by flow cytometry 
using a BD FACS Canto II (BD Biosciences), and data were analyzed 
using FlowJo software (Treestar). For all samples, at least 350 ba-
sophils were assessed. Basophil activation was calculated as the 







Specific IgE ImmunoCAP [kUA/L]
α- 
Gal Beef Milk α- LA β- LG Caseins BGG LF LPO Whey
1 M/56 GI, U n.d. 16 9.2 2.4 <0.1 <0.1 <0.1 0.49 1.39 0.18 0.38
2 F/50 AE, U Tolerant 4.9 0.46 0.11 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
3 F/59 AE, U, GI, ANA GI 27.3 15.8 5.57 <0.1 <0.1 0.17 2.9 4.48 0.9 1.7
4 M/34 GI GI 31 1.8 0.31 <0.1 <0.1 <0.1 0.14 0.49 <0.1 <0.1
5 M/53 U Tolerant 26 24 12 <0.1 <0.1 0.68 9 12 3.0 6.7
6 F/42 AE, U, ANA GI, U 23 6.8 1.4 <0.1 <0.1 <0.1 0.74 1.4 0.12 0.31
7 F/65 U, GI, ANA Tolerant 4.9 1.3 0.22 <0.1 <0.1 <0.1 0.16 0.23 <0.1 0.14
8 F/70 U, ANA n.d. 13 3.8 0.55 <0.1 <0.1 <0.1 0.23 0.35 <0.1 0.29
9 F/42 AE, U, GI, ANA GI 44 15 1.7 <0.1 <0.1 <0.1 1 2.8 0.18 0.73
10 M/64 AE, U GI 93 13 2.3 <0.1 <0.1 0.11 1.6 7.1 0.31 1.4
11 M/34 AE, U, GI, ANA GI 35 13 4.2 <0.1 <0.1 0.19 3.4 4.6 0.7 2.5
12 M/63 AE Tolerant 40 1.4 0.31 <0.1 <0.1 <0.1 <0.1 0.12 <0.1 <0.1
13 F/29 AE, U, GI Tolerant 14 4.3 0.46 <0.1 <0.1 <0.1 0.25 1.1 <0.1 0.11
14 F/42 AE, U, ANA Tolerant 95 25 5.6 <0.1 <0.1 0.35 5.2 n.d. n.d. 3.1
15 F/34 U, GI GI 95.2 32.5 5.07 0.1 0.17 0.26 3.1 4.2 0.82 1.4
16 M/52 AE, U, GI, ANA Tolerant 94 9.7 1.5 <0.1 <0.1 <0.1 0.57 n.d. n.d. 0.3
17 F/35 U, GI Tolerant 14 7.6 2.4 <0.1 <0.1 0.14 1.5 1.6 0.43 0.89
18 M/44 AE, U, GI, ANA Tolerant 34 14 3.8 <0.1 <0.1 0.11 2.2 n.d. n.d. 1.3
19 M/57 AE, U, GI, ANA GI, Ua  100 47 9.2 <0.1 <0.1 0.25 5.1 6.9 1.8 3.4
20 F/69 AE, U U 31 8.4 1.1 <0.1 <0.1 n.d. 0.45 0.82 0.19 0.28
21 F/37 AE, U, GI, ANA Tolerant 12 2.8 0.76 <0.1 <0.1 <0.1 0.78 1.1 0.13 0.69
22 F/43 AE, U, GI, ANA Tolerant 22 6 1.2 <0.1 <0.1 <0.1 0.55 0.98 <0.1 0.57
23 M/37 GI GIa  13 1.2 0.26 <0.1 <0.1 <0.1 0.21 0.36 <0.1 0.12
24 F/60 U, GI Tolerant 1.2 0.69 0.11 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
25 F/64 AE, U, GI GI 50 31 10 <0.1 <0.1 0.41 6.9 6.5 2.4 5.7
26 M/62 AE, U, GI, ANA GI, U 28 12 1.1 <0.1 <0.1 <0.1 0.68 0.79 <0.1 0.46
27 F/45 AE, U, ANA GI, U 100 26 2.2 <0.1 <0.1 0.43 5.3 8 2.2 4.7
28 M/60 AE, U, GI, ANA Tolerant 88 34 10 0.21 0.16 0.29 0.68 2.2 0.42 0.61
29 M/67 U, ANA Tolerant 10 3.9 0.88 <0.1 <0.1 <0.1 0.34 0.72 <0.1 0.25
30 F/29 AE, U, GI Tolerant 3.2 0.62 0.16 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
31 M/21 U, GI GI 11 2.6 0.36 <0.1 <0.1 <0.1 0.14 0.37 <0.1 <0.1
32 F/47 U, GI n.d. 43 4.1 0.37 <0.1 <0.1 <0.1 <0.1 0.44 <0.1 <0.1
33 M/54 U, AE n.d. 100 25 1.4 <0.1 <0.1 <0.1 0.63 3.3 0.15 0.46
34 F/66 U, AE, GI GI 21 5.3 0.42 <0.1 <0.1 <0.1 0.13 1.4 <0.1 0.13
35 M/46 GI GI 14 6.2 0.51 <0.1 <0.1 <0.1 0.3 0.52 0.12 0.26
36 F/56 U, AE, ANA U 57 23 2.7 <0.1 <0.1 <0.1 1.1 1.9 0.25 0.95
37 M/49 U, GI, ANA GI 43 13 1.8 <0.1 <0.1 <0.1 0.72 2.2 0.27 0.73
38 M30 GI Tolerant 17 6.2 0.88 <0.1 <0.1 <0.1 0.37 1.2 0.15 0.35
Abbreviations: α- LA, α- lactalbumin; β- LG, β- lactoglobulin; BGG, bovine γ- globulin; LF, lactoferrin; LPO, lactoperoxidase; ANA, anaphylaxis; AE, 
angioedema; GI, gastrointestinal symptoms; U, urticarial; n.d., not determined.
aExperience symptoms at each exposure to dairy products.
    |  5PERUSKO Et al.
percentage of CD63+ out of CD203c+ cells, and 5% CD63+ baso-
phils were set as cutoff for basophil activation.
2.6  |  Statistics
Data were analyzed using GraphPad Prism software, version 8. 
Mann– Whitney U test was used for comparisons between the groups. 
Spearman's rank correlation was used to calculate the strength of an 
association between two variables. Receiver operating characteris-
tic (ROC) curve analysis was performed to determine the diagnostic 
value of IgE levels. A p- value <0.05 was considered significant.
3  |  RESULTS
3.1  |  Patients clinical and allergen- specific IgE 
characteristics
The characteristics of the 38 Swedish AGS patients are shown in 
Table 1. All patients were IgE positive to α- Gal, beef, and milk. The 
IgE levels to α- Gal (median 28 kUA/L; range, 1.2– 100 kUA/L) and beef 
(median 8 kUA/L; range, 0.46– 47 kUA/L) were significantly higher 
(p < 0.0001) than those to milk (median 1.3 kUA/L; range, 0.11– 
12 kUA/L) (Figure 1A). Moderate to strong correlations between IgE 
levels to α- Gal and milk (ρ = 0.67, p < 0.0001) as well as between 
beef and milk (ρ = 0.93, p < 0.0001) were found (Figure S1A,B). 
Many AGS patients displayed low IgE levels to one or more of the 
major milk allergens (10 had IgE to caseins and 2 to α- lactalbumin, β- 
lactoglobulin, and caseins) although none were diagnosed with milk 
allergy. Based on the questionnaire data, 53% (18/34) of the AGS 
patients reported a history of allergic reactions to milk and dairy 
(Table 1). Six percent (2/34) reacted at each exposure to dairy prod-
ucts, while 47% (16/34) experienced reactions at certain exposures 
only, that depended on the amount consumed, type of dairy prod-
ucts, and cofactors. Reported symptoms were gastrointestinal (89%) 
and urticaria (33%). AGS patients with a history of allergic reactions 
to dairy had significantly higher IgE values to α- Gal (p < 0.05) com-
pared to patients who were tolerant to dairy products (Figure 1B). 
There were no significant differences in IgE levels to milk between 
the two groups (Figure 1B). ROC curve analysis was performed to 
investigate if differences in α- Gal IgE levels are robust enough to 
predict the occurrence of allergic reactions in individual patients. 
The analysis showed that α- Gal IgE levels could indeed discriminate 
F I G U R E  1  Allergen- specific IgE levels among AGS patients. (A) IgE levels to α- Gal, beef, and milk (kUA/L) (n = 38). (B) IgE levels to α- Gal 
and milk (kUA/L) among patients with a history of allergic reactions to milk and dairy products (n = 18) and patients who are tolerant to milk 
and dairy products (n = 16). (C) IgE levels to BGG, LF, LPO, and whey (kUA/L) among patients with a history of allergic reactions to milk and 
dairy products (n = 18) and patients who are tolerant to milk and dairy products (n = 16). Mann– Whitney U test was used for comparisons 
between the groups. * denotes p < 0.05, *** denotes p < 0.001, **** denotes p < 0.0001, and ns denotes no significant differences
(A) (B)
(C)
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between patients with and without reactions to dairy (p = 0.03), but 
the sensitivity and specificity were not sufficient to make measure-
ment of α- Gal IgE a useful test in the clinical practice for predicting 
allergic reactions (area under the curve was 0.72).
3.2  |  Unprocessed and pasteurized milk inhibit IgE 
binding to α- Gal
Unprocessed and pasteurized 3% and 1.5% fat milk were assessed 
for their ability to inhibit AGS patients’ IgE binding to α- Gal- HSA. 
All milk products exerted dose- dependent inhibition of α- Gal- 
specific IgE binding (Figure 2), showing the presence of α- Gal in 
unprocessed as well as in pasteurized milk recognized by patients’ 
IgE. Unprocessed milk was able to inhibit IgE binding to α- Gal up 
to 80%, and pasteurized milks (both 3% and 1.5% milk fat) up to 
58%.
3.3  |  AGS patients’ IgE antibodies recognize BGG, 
LF, and LPO but not major milk allergens
Next, the most prominent milk proteins α- casein, β- casein, κ- casein, 
α- lactalbumin, β- lactoglobulin, BGG, LF, LPO, BSA, and whey were 
selected to be examined for AGS patients’ IgE binding in immunoblot 
using the serum pool. Among the tested proteins, BGG, LF, and LPO 
were recognized by patients’ IgE (Figure 3A). LF was recognized with 
the strongest intensity. Whey proteins, naturally occurring milk pro-
teins after depletion of caseins, showed multiple bands which corre-
sponded to the molecular weights of BGG, LF, and LPO (Figure 3A). 
Interestingly, caseins, α- lactalbumin, β- lactoglobulin and BSA, major 
milk allergens in genuine milk allergy, were not recognized. The 
serum from a healthy control did not react with milk proteins (data 
not shown). Preincubation of the serum pool with 150 µg/ml of the 
α- Gal carrying glycoprotein bovine thyroglobulin, almost completely 
abrogated the IgE binding to BGG, LF, LPO, and whey (Figure 3B), 
providing further evidence that the IgE reactivity to these proteins 
was α- Gal dependent.
3.4  |  BGG, LF, and LPO are α- Gal carrying 
milk proteins
Milk proteins and whey were analyzed for the presence of the α- Gal 
epitope by performing an immunoblot with the anti- α- Gal antibody 
(chicken scFv anti- α- Gal). The immunoblot revealed that BGG, LF, 
and LPO are α- Gal carrying proteins in milk (Figure 3C). Whey pro-
teins showed multiple bands which mirrored the reactivity of puri-
fied BGG, LF, and LPO (Figure 3C).
3.5  |  IgE antibodies to BGG, LF, LPO, and whey are 
detected in the majority of AGS patients
IgE reactivity to BGG and whey was assessed in 38 AGS patients 
and to LF and LPO in 35 AGS patients by ImmunoCAP (Table 1). 
Eighty- nine percent of the patients were IgE positive to BGG (me-
dian 0.6 kUA/L; range, 0.1– 9.0 kUA/L), 91% to LF (median 1.2 kUA/L; 
range, 0.1– 12 kUA/L), 57% to LPO (median 0.13 kUA/L; range, 
0.1– 3 kUA/L), and 82% to whey (median 0.42 kUA/L; range, 0.1– 
6.7 kUA/L). Moderate positive correlations between IgE antibod-
ies to α- Gal and BGG (ρ = 0.61, p < 0.0001), α- Gal and LF (ρ = 0.73, 
p < 0.0001), α- Gal and LPO (ρ = 0.63, p < 0.0001), and between α- Gal 
and whey (ρ = 0.61, p < 0.0001) were observed (Figure S2), provid-
ing further evidence that IgE binding to these milk proteins is de-
pendent on α- Gal. AGS patients with a history of allergic reactions 
to dairy had significantly higher IgE levels to LF (p < 0.05) compared 
to patients who were tolerant to dairy products (Figure 1C). There 
were no significant differences in IgE levels to BGG, LPO, and whey 
between the groups, although there was a tendency of higher IgE 
levels for the group with reported allergic reactions to milk/dairy 
(Figure 1C). ROC curve analysis showed that LF IgE levels, similarly 
as to α- Gal IgE levels, could discriminate between AGS patients with 
and without allergic reactions to dairy (p = 0.03), but the sensitivity 
and specificity were not high (area under the curve was 0.73).
3.6  |  BGG, LF, LPO, and whey inhibit AGS patients’ 
IgE binding to α- Gal
The ability of BGG, LF, LPO, and whey to inhibit AGS patients’ IgE 
binding to α- Gal was tested in inhibition ELISA using the serum pool 
and two individual sera. All tested milk proteins inhibited α- Gal- 
specific IgE binding in a dose- dependent manner in the serum pool 
and in individual sera (Figure 4). BGG, LPO, and whey showed similar 
inhibition pattern, while the pattern of LF differed. LF’s inhibition 
potency was the least dependent on concentration. BGG and whey 
F I G U R E  2  Inhibition of patients’ IgE binding to α- Gal- HSA 
by unprocessed and pasteurized milk. The serum pool from AGS 
patients was preincubated with two- fold dilutions of unprocessed 
milk, pasteurized 3% and 1.5% fat milk, and the remaining 
binding to α- Gal was determined in inhibition ELISA. Percentage 
inhibition of IgE binding is presented
    |  7PERUSKO Et al.
F I G U R E  3  Immunoblot analysis of milk proteins. (A) IgE binding to milk proteins and whey in the serum pool from AGS patients. (B) 
Inhibition of IgE binding to milk proteins and whey by preincubating the serum pool with 150 µg/ml of bovine thyroglobulin. (C) Anti- α- Gal 
antibody binding to milk proteins and whey. α- cas, α- casein; β- cas, β- casein; κ- cas, κ- casein; α- LA, α- lactalbumin; β- LG, β- lactoglobulin; BGG, 
bovine γ- globulin; LF, lactoferrin; LPO, lactoperoxidase; BSA, bovine serum albumin; Mw, molecular weight markers (kDa)
F I G U R E  4  Inhibition ELISA. Inhibition of IgE binding to α- Gal by milk proteins and homologous inhibitor. Serum pool or individual sera 
were preincubated with two- fold dilutions of BGG, LF, LPO, whey, orα- Gal- HSA and α- Gal- specific IgE binding was determined. Percentage 
inhibition of IgE binding in relation to the concentration of the inhibitors is shown
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induced the highest degree of inhibition at the highest concentra-
tions, but LF was the most potent inhibitor of α- Gal- specific IgE 
binding in the lower range of concentrations. At the highest concen-
tration (1000 µg/ml), BGG achieved inhibition up to 79%, LF up to 
70%, LPO up to 64%, and whey up to 79%.
3.7  |  Milk, BGG, LF, LPO, and whey activated 
basophils of AGS patients
The allergenic activity of milk and milk proteins was investigated by 
basophil activation test among 25 patients with AGS (#7– 13, 22– 39 in 
Table 1), two non- atopic, and two atopic controls. Milk and milk pro-
teins activated basophils (>5%) in nearly all patients (milk 23/25; BGG 
21/25; LF 7/8, LPO 12/12; and whey 14/18) (Figure 5A,B). LF induced 
maximum basophil reactivity with lower doses (10 µg/ml) compared 
to BGG and LPO (100 and 200 µg/ml) (Figure 5B). Interestingly, whey 
that contains all three allergens showed a reactivity that closely re-
sembled LF. None of the milk proteins activated basophils in control 
subjects.
4  |  DISCUSSION
Bovine milk and dairy products have been reported to induce aller-
gic reactions in AGS patients, and IgE reactivity to milk is common 
among these patients.4,13,15 Here, we examined milk and the major 
milk proteins for their recognition by IgE and allergenicity among 
AGS patients, as well as for being carriers of α- Gal. We found for 
the first time that BGG, LF, and LPO are relevant milk allergens for 
AGS patients. LF was strongly recognized by patients’ IgE and was 
the major α- Gal carrying milk protein. With respect to allergenic-
ity, BGG, LF, and LPO were all shown to activate AGS patients’ 
basophils. We found that more than 50% of our AGS patients had 
a history of allergic reactions to milk or dairy products, but only 
6% reacted at each exposure to milk/dairy. We observed that the 
IgE levels to α- Gal and LF were significantly higher in the group 
of AGS patients with allergic reactions to milk/dairy compared to 
the tolerant group. ROC curve analysis showed that the IgE levels 
could discriminate between patients with and without reactions 
to dairy, but the sensitivity and specificity were not sufficient to 
make measurement of α- Gal or LF IgE levels a useful test in the 
clinical practice for predicting allergic reactions.
Milk proteins constitute two main protein fractions, caseins 
and whey. The caseins contain α- casein, β- casein, and κ- casein, and 
whey proteins contain α- lactalbumin, β- lactoglobulin, BSA, BGG, LF, 
LPO, and other proteins in minute amounts.22,23 These milk proteins, 
except LPO, are known allergens of relevance in genuine milk allergy, 
of which caseins and β- lactoglobulin are dominating. Our AGS pa-
tients with IgE to milk demonstrated different reactivity patterns 
against the milk proteins. They recognized LF as the major allergen in 
addition to BGG and LPO. BGG has previously been found as a major 
IgE reactive protein from beef extract among AGS patients.19 Many 
mammalian (eg, murine, equine, ovine, feline) immunoglobulins are 
known to be carriers of α- Gal, and BGG is one among them.24– 27 To 
our knowledge, we show for the first time that LPO is an IgE- binding 
milk protein with allergenic activity. Our findings are in line with the 
results by Kennedy et al. who showed that caseins, α- lactalbumin, 
and β- lactoglobulin were not responsible for AGS patients’ IgE re-
activity to milk.5
We thoroughly characterized the AGS patients’ IgE binding to pu-
rified BGG, LF, and LPO. Nearly all patients displayed IgE reactivity 
to BGG and LF and more than 50% to LPO. Patients’ IgE showed 
the strongest reactivity with LF (evidenced as the strongest IgE re-
active band in immunoblot, and highest IgE levels determined by 
ImmunoCAP). We noted that the IgE binding to BGG, LF, LPO, and 
whey was α- Gal- dependent. However, only small amounts of α- Gal 
are present on their surfaces which are reflected in the lower IgE 
levels against these proteins compared to α- Gal. The inhibition ELISA 
experiments also revealed that all three IgE reactive milk proteins 
F I G U R E  5  Percentage of CD63+ basophils among 25 AGS patients activated by different dilutions of (A) milk and (B) milk proteins. BGG, 
bovine γ- globulin; LF, lactoferrin; LPO, lactoperoxidase
(A) (B)
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contain small amounts of α- Gal since high concentrations were 
needed to achieve inhibition. The inhibition pattern of LF resembled 
the homologous inhibition of α- Gal- HSA, and among the milk pro-
teins, it was the most potent inhibitor of α- Gal- specific IgE binding 
at low concentrations. Differences in reactivity patterns of BGG, LF, 
and LPO suggest that there are several factors influencing α- Gal- 
specific IgE binding. These can be (a) the amount of α- Gal epitope 
present on the protein, (b) protein microenvironment in proximity to 
the α- Gal epitope, (c) representation of α- Gal in the form of mono- , 
bi- , or tri- antennary glycans,28 and (d) inhibitory activity of anti- α- Gal 
IgG, IgA, and IgM antibodies present in patients’ serum.29
With respect to allergenicity, milk, BGG, LF, LPO, and whey 
were all shown to induce basophil activation in the majority of AGS 
patients. The maximum basophil reactivity with LF was achieved 
at lower doses compared to BGG and LPO. This finding correlates 
well with LF’s higher IgE- binding capacity at lower concentrations. 
Interestingly, we have previously shown that sensitization to LF is 
associated with anaphylaxis in AGS patients.30 Thus, the higher ba-
sophil sensitivity to LF might contribute to its role in anaphylaxis. 
Moreover, the maximum basophil reactivity with milk was achieved 
at ~10 times higher doses than with meat extract (unpublished data). 
BGG and LPO induced maximum basophil reactivity at concentra-
tions ~10 times higher than for LF. Purified α- Gal- containing pork al-
lergens, that are considered as the most potent meat allergens, have 
effective doses approximately 100 times lower.20 The ability of milk 
and milk proteins to induce basophil degranulation is in line with the 
fact that many AGS patients react to milk consumption.
It is important to mention that alpha- Gal carrying glycolipids are 
assumed to participate in the allergic effector phase in AGS syn-
drome.31 They have been demonstrated to bind patients’ IgE and 
activate their basophils.32 However, alpha- Gal carrying glycolipids 
from milk remain to be identified and their role in reactions to milk 
and dairy to be investigated.
In conclusion, BGG, LF, and LPO are major bovine milk α- Gal car-
rying proteins that are recognized by AGS patients’ IgE and activate 
their basophils. LPO was for the first time shown to be an allergen. 
Although milk products are not the most potent inducers of allergic 
symptoms in AGS patients, they contribute to allergic manifesta-
tions, especially gastrointestinal symptoms and urticaria.
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